Smith & Nephew Reorganization May Foreshadow Imminent Zimmer Purchase
This article was originally published in The Gray Sheet
Executive Summary
Smith & Nephew's recently announced corporate restructuring plan portends a possible acquisition of Bristol Myers Squibb's $1.8 bil. Medical Devices Group, which includes the Zimmer orthopedics and Convatec wound management businesses.
You may also be interested in...
Exogen Acquisition Gives Smith & Nephew Ultrasound Fracture Product
Smith & Nephew will add a non-invasive ultrasound fracture healing system to its orthopedic product line through the purchase of Piscataway, New Jersey-based Exogen. A definitive agreement for the $68 mil. cash deal was announced July 26.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.